Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)
Apply
Lenvatinib
Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step